Engineers Gate Manager LP - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 124 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.

Quarter-by-quarter ownership
Engineers Gate Manager LP ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2021$84,000
-33.9%
12,000
-13.0%
0.01%
-37.5%
Q2 2021$127,000
-35.5%
13,800
-32.0%
0.01%
-20.0%
Q1 2021$197,000
-40.5%
20,300
-37.0%
0.01%
-28.6%
Q4 2020$331,000
+128.3%
32,220
+123.9%
0.01%
+100.0%
Q3 2020$145,000
-56.7%
14,392
-55.2%
0.01%
-58.8%
Q2 2020$335,000
+7.7%
32,120
-9.5%
0.02%
+21.4%
Q4 2019$311,000
+6.9%
35,501
+55.1%
0.01%
-12.5%
Q2 2019$291,00022,8850.02%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$5,108,0002.15%
Camber Capital Management LP 4,235,000$12,070,0000.52%
Kynam Capital Management, LP 579,915$1,653,0000.42%
GLOBEFLEX CAPITAL L P 419,322$1,195,0000.29%
Eversept Partners, LP 1,435,077$4,089,9690.29%
ARMISTICE CAPITAL, LLC 1,500,000$4,275,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 506,066$1,442,0000.07%
XTX Topco Ltd 36,130$103,0000.04%
State of Wyoming 20,732$59,0000.04%
Patriot Financial Group Insurance Agency, LLC 55,500$158,0000.03%
View complete list of PUMA BIOTECHNOLOGY INC shareholders